Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by blomskompskieson Jun 18, 2016 10:11am

168 Views

Post# 24976860

RE:RE:RE:RE: News: Positive Safety and Efficacy Data for Skin Lightening

Totally thought that it was new news but its not april 18th...i must be tired. According to a post on sironas site they expect a 90$ million dollar upfront payment for licensing their 1067 skin lightner by the end of 2016 Q2. This was their own goal deadline and i'd like to see them make that deadline.

Bullboard Posts

Options trading in a volatile macro environment